Lesions of the Ovary and Fallopian Tubedoi: 10.1056/NEJMc2212426pmid: 36322862
To the Editor: In their review on lesions of the ovary and fallopian tube, Sisodia and del Carmen (Aug. 25 issue)1 describe strategies for determining the likelihood of a lesion being malignant. We fully agree that risk stratification for adnexal lesions is essential, since many patients with lesions that appear to be benign can be treated conservatively.2 However, the only diagnostic imaging tools that are mentioned are the International Ovarian Tumor Analysis (IOTA) simple rules and the Ovarian-Adnexal Reporting and Data System (O-RADS). We think that this article is incomplete without mentioning the IOTA Assessment of Different Neoplasias in the . . .
Application of High-Sensitivity Troponin in Suspected Myocardial Infarctiondoi: 10.1056/NEJMx220009pmid: 36322864
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction (N Engl J Med 2019;380:2529-2540). The list of authors (page 2529) should have ended, “for the COMPASS-MI Study Group,” and the author footnotes should have included a footnote about the study group: “A list of investigators in the COMPASS-MI Study Group is provided in the Supplementary Appendix, available at NEJM.org.” The article is correct and the Supplementary Appendix has been replaced at NEJM.org. . . .
The Worst ThingAdrian, Chris
doi: 10.1056/NEJMp2210242pmid: 36317746
The Worst ThingSupporting bereaved parents revisiting the worst pain of their lives at a psychedelic retreat, a palliative care physician and chaplain is cast back into his own family story of violence, heartache, and traumatic death.